BIOLIGHT(SZ:300246) Xin Lang Cai Jing·2026-01-16 06:05Group 1 - The core point of the news is that Baolait has experienced a significant stock price increase of 60.82% over the past six days, with a current price of 14.45 yuan per share and a market capitalization of 3.823 billion yuan [1] - Baolait Medical Technology Co., Ltd. is based in Zhuhai, Guangdong, and was established on June 28, 1993, with its listing date on July 19, 2011. The company specializes in the research, production, sales, and service of medical device products [1] - The main revenue composition of Baolait includes 77.51% from blood dialysis products, 21.39% from monitoring devices, and 1.10% from other supplementary products [1] Group 2 - Among Baolait's top ten circulating shareholders, a fund under CITIC Prudential, specifically the CITIC Prudential Multi-Strategy Mixed (LOF) A (165531), has entered the top ten shareholders, holding 1.055 million shares, which is 0.5% of the circulating shares [2] - The fund has generated a floating profit of approximately 738,500 yuan today and a total floating profit of 5.4863 million yuan during the six-day price increase [2] - The CITIC Prudential Multi-Strategy Mixed (LOF) A fund was established on June 16, 2017, with a current scale of 1.133 billion yuan, and has achieved a year-to-date return of 5.42% and a one-year return of 51.95% [2]